-transparent.png){kind=logo}
The human nucleolar antigen p120 was detected with an anti-p120 monoclonal antibody (MAbp120) in most human malignant tumors (Freeman et al., Cancer Research, 48, 1244-1251, 1988). Stable transfection of the sense p120 cDNA caused malignant transformation of NIH/3T3 cells in vitro, and the antisense p120 constructs markedly delayed the growth of these transformed cells (Perlaky et al., Cancer Research, 52, 428-436, 1992). Several p120 antisense phosphorothioate oligonucleotides designed to hybridize with different regions of the p120 sequence were screened on human tumor cell lines in vitro. Marked growth inhibition of HeLa, LOX and HRCC cell lines was found, particularly with antisense p120 oligonucleotide ISIS 3466 in combination with N-[1-(2,3-dioleyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTMA); oligonucleotide ISIS 3466 is complementary to a non-translated region at the 3' end of the molecule. Preliminary in vivo studies on human LOX ascites tumor in nude mice showed marked inhibitory effects on tumor growth by the antisense oligonucleotide ISIS 3466 in the presence of DOTMA when treated on alternate days.
L Perlaky, and
Y Saijo, and
R K Busch, and
C F Bennett, and
C K Mirabelli, and
S T Crooke, and
H Busch
August 1991,
The Journal of clinical investigation,
L Perlaky, and
Y Saijo, and
R K Busch, and
C F Bennett, and
C K Mirabelli, and
S T Crooke, and
H Busch
May 1992,
Blood,
L Perlaky, and
Y Saijo, and
R K Busch, and
C F Bennett, and
C K Mirabelli, and
S T Crooke, and
H Busch
December 2004,
Journal of experimental therapeutics & oncology,
L Perlaky, and
Y Saijo, and
R K Busch, and
C F Bennett, and
C K Mirabelli, and
S T Crooke, and
H Busch
November 1994,
Biochemical pharmacology,
L Perlaky, and
Y Saijo, and
R K Busch, and
C F Bennett, and
C K Mirabelli, and
S T Crooke, and
H Busch
January 1999,
Cancer letters,
L Perlaky, and
Y Saijo, and
R K Busch, and
C F Bennett, and
C K Mirabelli, and
S T Crooke, and
H Busch
September 1995,
Cancer research,
L Perlaky, and
Y Saijo, and
R K Busch, and
C F Bennett, and
C K Mirabelli, and
S T Crooke, and
H Busch
January 2005,
Cancer letters,
L Perlaky, and
Y Saijo, and
R K Busch, and
C F Bennett, and
C K Mirabelli, and
S T Crooke, and
H Busch
January 2001,
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.],
L Perlaky, and
Y Saijo, and
R K Busch, and
C F Bennett, and
C K Mirabelli, and
S T Crooke, and
H Busch
October 2001,
Investigative ophthalmology & visual science,
L Perlaky, and
Y Saijo, and
R K Busch, and
C F Bennett, and
C K Mirabelli, and
S T Crooke, and
H Busch
March 2007,
Acta pharmacologica Sinica,
